Hemera goes to Brussels for the Final Phase of the EIC Accelerator

Hemera is among the 7 Italian startups out of 71 selected across Europe, that successfully passed the second phase of the EIC Accelerator selection process, the prestigious European Union program supporting highly innovative SMEs and startups. Hemera has now received...

Research by Hemera Scientists on Nature Immunology Review

The study titled “Tumor-associated macrophages enhance tumor innervation and spinal cord repair”, to which our researchers contributed, was recently published by Nature Reviews Immunology—one of the most authoritative journals in the field of immunology and a global...

Hemera Receives a “GO” in Phase 1 of the EIC Accelerator

Hemera submitted its application to the first phase of the EIC Accelerator program, a European Union initiative designed to support SMEs and startups with highly innovative projects capable of creating new markets or transforming existing ones. We are pleased to...